{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:04:17Z","timestamp":1790859857295,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.psyneuen.2010.12.018","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T01:29:52Z","timestamp":1295832592000},"page":"1092-1096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia"],"prefix":"10.1016","volume":"36","author":[{"given":"Paul C.","family":"Guest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura W.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Markus","family":"Leweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Rothermundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico (J.M.)","family":"van Beveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Rahmoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2010.12.018_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/JOE-09-0461","article-title":"Obesity induced by high-fat diet promotes insulin resistance in the ovary","volume":"206","author":"Akamine","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0010","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0016-5085(03)00216-6","article-title":"Characterization of the effects of pancreatic polypeptide in the regulation of energy balance","volume":"124","author":"Asakawa","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tem.2006.02.005","article-title":"Focus on prolactin as a metabolic hormone","volume":"17","author":"Ben-Jonathan","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1074\/mcp.M900372-MCP200","article-title":"Identification of targeted analyte clusters for studies of schizophrenia","volume":"9","author":"Cheng","year":"2010","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.psyneuen.2010.12.018_bib0025","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","article-title":"Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections","volume":"5","author":"Domenici","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1152\/physiolgenomics.00164.2009","article-title":"Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification","volume":"40","author":"Friese","year":"2010","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.yhbeh.2006.06.029","article-title":"Sex, hormones and affective arousal circuitry dysfunction in schizophrenia","volume":"50","author":"Goldstein","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/mp.2009.81","article-title":"Increased levels of circulating insulin-related peptides in first-onset, antipsychotic na\u0131ve schizophrenia patients","volume":"15","author":"Guest","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0045","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00018-007-7254-0","article-title":"The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties","volume":"64","author":"Helle","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-1781(92)90107-E","article-title":"Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects","volume":"41","author":"Kahn","year":"1992","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0002-9378(16)32480-2","article-title":"Metabolic effects of progesterone","volume":"142","author":"Kalkhoff","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0893-133X(00)00201-3","article-title":"The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia","volume":"24","author":"Meltzer","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1","volume":"101","author":"Meyer","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2265.2005.02194.x","article-title":"Insulin sensitivity is impaired in adults with varying degrees of GH deficiency","volume":"62","author":"Murray","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.plefa.2006.02.002","article-title":"Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls","volume":"74","author":"Nilsson","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/jcem-57-3-529","article-title":"Insulin resistance in Cushing's syndrome","volume":"57","author":"Nosadini","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0024-3205(02)01646-6","article-title":"Physical consequences of schizophrenia and its treatment: the metabolic syndrome","volume":"71","author":"Ryan","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4137\/BMI.S4877","article-title":"Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia","volume":"5","author":"Schwarz","year":"2010","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-na\u00efve patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet. Med."},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.mp.4001475","article-title":"Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE)","volume":"9","author":"Swatton","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endo-99-3-720","article-title":"Ultradian growth hormone rhythm in the rat: effects of feeding, hyperglycemia, and insulin-induced hypoglycemia","volume":"99","author":"Tannenbaum","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2010.12.018_bib0110","first-page":"1627","article-title":"Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis","volume":"277","author":"Walker","year":"2010","journal-title":"Proc. Biol. Sci."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453011000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453011000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:37:05Z","timestamp":1759682225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453011000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0306453011000060"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2010.12.018","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2010.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}